BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu Y, Deforest M, Grabell J, Hopman W, James P. Relative contributions of bleeding scores and iron status on health-related quality of life in von Willebrand disease: a cross-sectional study. Haemophilia 2017;23:115-21. [DOI: 10.1111/hae.13062] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 van Hoorn ES, Houwing ME, Al Arashi W, Leebeek FWG, Hazelzet JA, Gouw SC, Schutgens REG, Schols SEM, Lingsma HF, Cnossen MH; SYMPHONY consortium. Patient-reported outcomes in autosomal inherited bleeding disorders: A systematic literature review. Haemophilia 2022. [PMID: 35040234 DOI: 10.1111/hae.14492] [Reference Citation Analysis]
2 Allen G, Du P, Khair K, Lee HY, Ozelo MC, Berthoz FT, Windyga J. Addressing unmet needs in rare bleeding disorders: selected poster extracts of recent research in hemophilia A and von Willebrand disease presented at the 14th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD) (Feb 3-5, 2021; virtual congress). Expert Rev Hematol 2021;:1-18. [PMID: 34369834 DOI: 10.1080/17474086.2021.1963706] [Reference Citation Analysis]
3 Lenting PJ, Kizlik-Manson C, Casari C. Towards novel treatment options in von Willebrand disease. Haemophilia 2022;28 Suppl 4:5-10. [PMID: 35521728 DOI: 10.1111/hae.14518] [Reference Citation Analysis]
4 Denis CV, Susen S, Lenting PJ. von Willebrand disease: what does the future hold? Blood 2021;137:2299-306. [PMID: 33662989 DOI: 10.1182/blood.2020008501] [Reference Citation Analysis]
5 Vandermeulen H, Sholzberg M. Iron deficiency and anemia in patients with inherited bleeding disorders. Transfusion and Apheresis Science 2018;57:735-8. [DOI: 10.1016/j.transci.2018.10.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
6 Sanigorska A, Chaplin S, Holland M, Khair K, Pollard D. The lived experience of women with a bleeding disorder: A systematic review. Res Pract Thromb Haemost 2022;6. [DOI: 10.1002/rth2.12652] [Reference Citation Analysis]
7 Friend BD, Roach GD, Kempert PH, Moore TB. Successful Use of Hematopoietic Stem Cell Transplantation for 2 Pediatric Cases of Glanzmann Thrombasthenia and Review of the Literature. J Pediatr Hematol Oncol 2020;42:e521-6. [PMID: 31693514 DOI: 10.1097/MPH.0000000000001646] [Reference Citation Analysis]
8 El Alayli A, Brignardello Petersen R, Husainat NM, Kalot MA, Aljabiri Y, Turkmani H, Britt A, El-Khechen H, Shahid S, Roller J, Motaghi S, Mansour R, Tosetto A, Abdul-Kadir R, Laffan M, Weyand A, Leebeek FWG, Arapshian A, Kouides P, James P, Connell NT, Flood VH, Mustafa RA. Outcomes of long-term von Willebrand factor prophylaxis use in von Willebrand disease: A systematic literature review. Haemophilia 2022. [PMID: 35339117 DOI: 10.1111/hae.14550] [Reference Citation Analysis]
9 Lavin M, Aguila S, Dalton N, Nolan M, Byrne M, Ryan K, White B, O'Connell NM, O'Sullivan JM, Di Paola J, James PD, O'Donnell JS. Significant gynecological bleeding in women with low von Willebrand factor levels. Blood Adv 2018;2:1784-91. [PMID: 30042144 DOI: 10.1182/bloodadvances.2018017418] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 13.7] [Reference Citation Analysis]
10 Blaauwgeers MW, Kruip MJHA, Beckers EAM, Coppens M, Eikenboom J, van Galen KPM, Tamminga RYJ, Urbanus RT, Schutgens REG; TiN study group. Congenital platelet disorders and health status-related quality of life. Res Pract Thromb Haemost 2020;4:100-5. [PMID: 31989090 DOI: 10.1002/rth2.12281] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]